Cargando…
Humoral Response in SARS-CoV-2 Convalescent Compared to Vaccinated Kidney Transplant Patients
Autores principales: | Schimpf, Judith, Sprenger-Mähr, Hannelore, Davidovic, Tamara, Lhotta, Karl, Zitt, Emanuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842381/ https://www.ncbi.nlm.nih.gov/pubmed/35185362 http://dx.doi.org/10.3389/ti.2021.10060 |
Ejemplares similares
-
Enhanced SARS-CoV-2 Antibody Response After a Third Heterologous Vector Vaccine Ad26COVS1 Dose in mRNA Vaccine-Primed Kidney Transplant Recipients
por: Schimpf, Judith, et al.
Publicado: (2022) -
Waning humoral response 6 months after SARS-CoV-2 vaccination with the mRNA-BNT162b2 vaccine in hemodialysis patients: time for a boost
por: Davidovic, Tamara, et al.
Publicado: (2021) -
Humoral and Cellular Immune Response After a 3-Dose Heterologous SARS-CoV-2 Vaccination Using the mRNA-BNT162b2 and Viral Vector Ad26COVS1 Vaccine in Hemodialysis Patients
por: Davidovic, Tamara, et al.
Publicado: (2022) -
De Novo and Relapsing Glomerulonephritis following SARS-CoV-2 mRNA Vaccination in Microscopic Polyangiitis
por: Davidovic, Tamara, et al.
Publicado: (2021) -
The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients
por: Zitt, Emanuel, et al.
Publicado: (2021)